These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 19682862)
61. Comparison of the effects of fourth-generation fluoroquinolones on epithelial healing after photorefractive keratectomy. Shin JH; Lee HB; Park HY Cornea; 2010 Nov; 29(11):1236-40. PubMed ID: 20697276 [TBL] [Abstract][Full Text] [Related]
62. In vitro antifungal activity of the fourth generation fluoroquinolones against Candida isolates from human ocular infections. Ozdek SC; Miller D; Flynn PM; Flynn HW Ocul Immunol Inflamm; 2006 Dec; 14(6):347-51. PubMed ID: 17162605 [TBL] [Abstract][Full Text] [Related]
63. Treatment of Brucellosis in Guinea Pigs via a Combination of Engineered Novel pH-Responsive Curcumin Niosome Hydrogel and Doxycycline-Loaded Chitosan-Sodium Alginate Nanoparticles: an In Vitro and In Vivo Study. Abo El-Ela FI; Hussein KH; El-Banna HA; Gamal A; Rouby S; Menshawy AMS; El-Nahass ES; Anwar S; Zeinhom MMA; Salem HF; Al-Sayed MAY; El-Newery HA; Shokier KAM; El-Nesr KA; Hosein HI AAPS PharmSciTech; 2020 Nov; 21(8):326. PubMed ID: 33206259 [TBL] [Abstract][Full Text] [Related]
64. In vitro activities of six new fluoroquinolones against Brucella melitensis. Trujillano-Martín I; García-Sánchez E; Martínez IM; Fresnadillo MJ; García-Sánchez JE; García-Rodríguez JA Antimicrob Agents Chemother; 1999 Jan; 43(1):194-5. PubMed ID: 9869594 [TBL] [Abstract][Full Text] [Related]
65. [Study of efficacy of modern fluoroquinolones against agent of glanders in experiments in vivo]. Bondareva TA; Borisevich IV; Kalininskiĭ VB; Bondarev VP; Fomenkov OO Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):10-3. PubMed ID: 19623715 [TBL] [Abstract][Full Text] [Related]
66. The effect of long-term ethanol feeding on efficacy of doxycycline plus rifampicin in the treatment of experimental brucellosis caused by Brucella melitensis in rats. Yumuk Z; Dundar V J Chemother; 2005 Oct; 17(5):509-13. PubMed ID: 16323439 [TBL] [Abstract][Full Text] [Related]
67. Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Meisel C; Prass K; Braun J; Victorov I; Wolf T; Megow D; Halle E; Volk HD; Dirnagl U; Meisel A Stroke; 2004 Jan; 35(1):2-6. PubMed ID: 14684767 [TBL] [Abstract][Full Text] [Related]
68. Effect of early antibiotic treatment on the antibody response to cytoplasmic proteins of Brucella melitensis in mice. Bowden RA; Racaro GC; Baldi PC Clin Diagn Lab Immunol; 1999 May; 6(3):440-3. PubMed ID: 10225853 [TBL] [Abstract][Full Text] [Related]
71. [Efficacy of moxifloxacin (Avelox) in prophylaxis of infection in patients with profound neutropenia]. Minenko SV; Dmitrieva NV; Sokolova EN; Zhukov NV; Ptushkin VV Antibiot Khimioter; 2004; 49(3):26-31. PubMed ID: 15344394 [TBL] [Abstract][Full Text] [Related]
72. Exposure to Brucella in the laboratory. Zervos MJ; Bostic G Lancet; 1997 Mar; 349(9052):651. PubMed ID: 9057755 [No Abstract] [Full Text] [Related]
73. Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study. Khan W; Sullivan KL; McCann JW; Gonsalves CF; Sato T; Eschelman DJ; Brown DB AJR Am J Roentgenol; 2011 Aug; 197(2):W343-5. PubMed ID: 21785063 [TBL] [Abstract][Full Text] [Related]
74. Doxycycline-encapsulated solid lipid nanoparticles for the enhanced antibacterial potential to treat the chronic brucellosis and preventing its relapse: in vivo study. Hosseini SM; Farmany A; Abbasalipourkabir R; Soleimani Asl S; Nourian A; Arabestani MR Ann Clin Microbiol Antimicrob; 2019 Nov; 18(1):33. PubMed ID: 31706304 [TBL] [Abstract][Full Text] [Related]
75. Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropenia in patients with hematological malignancies. Shinohara A; Yoshiki Y; Masamoto Y; Hangaishi A; Nannya Y; Kurokawa M Leuk Lymphoma; 2013 Apr; 54(4):794-8. PubMed ID: 22978686 [TBL] [Abstract][Full Text] [Related]
76. [New indications for novel fluoroquinolones: moxifloxacin in the treatment of nosocomial infections]. Beloborodova NV; Popov DA; Vostrikova TIu; Bachinskaia EN; Kuznetsova ST Antibiot Khimioter; 2009; 54(1-2):25-6, 28-30. PubMed ID: 19499714 [No Abstract] [Full Text] [Related]
77. Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin. Lang R; Shasha B; Rubinstein E Antimicrob Agents Chemother; 1993 Nov; 37(11):2333-6. PubMed ID: 8285615 [TBL] [Abstract][Full Text] [Related]
78. Antibiotic selection and resistance issues with fluoroquinolones and doxycycline against bioterrorism agents. Brouillard JE; Terriff CM; Tofan A; Garrison MW Pharmacotherapy; 2006 Jan; 26(1):3-14. PubMed ID: 16506347 [TBL] [Abstract][Full Text] [Related]